Neutralization of neutrophin-3 in the ventral tegmental area or nucleus accumbens differentially modulates cocaine-induced behavioral plasticity in rats

Synapse

Volumn 46, Issue 2, 2002, Pages 57-65

  Freeman, Antoinette Y ^a   Pierce, R Christopher ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavioral sensitization; Brain derived neurotrophic factor; Psychostimulant

Indexed keywords

COCAINE; NEUROTROPHIN 3; NEUROTROPIC AGENT; NEUTRALIZING ANTIBODY;

ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG SENSITIZATION; HYPERACTIVITY; MALE; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SENSITIZATION; VENTRAL TEGMENTUM;

ANIMALS; ANTIBODIES; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; COCAINE; DOPAMINE UPTAKE INHIBITORS; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROTROPHIN 3; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; VENTRAL TEGMENTAL AREA;

EID: 0036837248     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10123     Document Type: Article

References (76)

1. Akerud P, Alberch J, Eketjall S, Wagner J, Arenas E. 1999. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. J Neurochem 73:70-8.
2. Altar CA, DiStefano PS. 1998. Neurotrophin trafficking by anterograde transport. Trends Neurosci 21:433-437.
3. Altar CA, Boylan CB, Jackson C, Hershenson S, Miller J, Wiegand SJ, Lindsay RM, Hyman C. 1992. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci USA 89:11347-11351.
4. 125I]NT-3. Eur J Neurosci 6:1389-1405.
5. Bemelmans AP, Horellou P, Pradier L, Brunet I, Colin P, Mallet J. 1999. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer. Hum Gene Ther 10:2987-2997.
6. Berhow MT, Hiroi N, Nestler EJ. 1996. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16:4707-4715.
7. Canals JM, Checa N, Marco S, Michels A, Perez-Navarro E, Alberch J. 1999. The neurotrophin receptors trkA, trkB and trkC are differentially regulated after excitotoxic lesion in rat striatum. Mol Brain Res 69:242-248.
8. Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ. 1998. Regulation of cocaine reward by CREB. Science 282:2272-2275.
9. Castren E, Thoenen H, Lindholm D. 1995. Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience 64:71-80.
10. Ceccatelli S, Ernfors P, Villar MJ, Persson H, Hokfelt T. 1991. Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment. Proc Natl Acad Sci USA 88:10352-10356.
11. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S. 1997. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17:2295-2313.
12. Costantini LC, Feinstein SC, Radeke MJ, Snyder-Keller A. 1999. Compartmental expression of trkB receptor protein in the developing striatum. Neuroscience 89:505-513.
13. Elmer E, Kokaia M, Ernfors P, Ferencz I, Kokaia Z, Lindvall O. 1997. Suppressed kindling epileptogenesis and perturbed BDNF and trkB gene regulation in NT-3 mutant mice. Exp Neurol 145:93-103.
14. Ernfors P, Wetmore C, Olson L, Persson H. 1990. Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron 5:511-526.
15. Fallon JH, Moore RY. 1978. Catecholamine innervation of basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and striatum. J Comp Neurol 180:545-580.
16. Flores C, Stewart J. 2000a. Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long-lasting sensitization to stimulant drugs: studies in the rat. Psychopharmacology 151:152-165.
17. Flores C, Stewart J. 2000b. Changes in astrocytic basic fibroblast growth factor expression during and after prolonged exposure to escalating doses of amphetamine. Neuroscience 98:287-293.
18. Flores C, Rodaros D, Stewart J. 1998. Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist. J Neurosci 18:9547-9555.
19. Frim DM, Uhler TA, Galpern WR, Beal MF, Breakefield XO, Isacson O. 1994. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc Natl Acad Sci USA 91:5104-5108.
20. Fryer RH, Kaplan DR, Feinstein SC, Radeke MJ, Grayson DR, Kromer LF. 1996. Developmental and mature expression of full-length and truncated TrkB receptors in the rat forebrain. J Comp Neurol 374:21-40.
21. Furukawa S, Sugihara Y, Iwasaki F, Fukumitsu H, Nitta A, Nomoto H, Furukawa Y. 1998. Brain-derived neurotrophic factor-like immunoreactivity in the adult rat central nervous system predominantly distributed in neurons with substantial amounts of brain-derived neurotrophic factor messenger RNA or responsiveness to brain-derived neurotrophic factor. Neuroscience 82:653-670.
22. Gall CM, Gold SJ, Isackson PJ, Seroogy KB. 1992. Brain-derived neurotrophic factor and neurotrophin 3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons. Mol Cell Neurosci 3:56-63.
23. Haycock JW, Ahn NG, Cobb MH, Krebs EG. 1992. ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc Natl Acad Sci USA 89:2365-2369.
24. Horger BA, Iyasere CA, Berhow MT, Messer CJ, Nestler EJ, Taylor JR. 1999. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 19:4110-4122.
25. Hung HC, Lee EH. 1996. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression. Brain Res Mol Brain Res 41:14-26.
26. Hyman C, Hofer M, Barde Y-A, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM. 1991. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232.
27. Impey S, Obrietan K, Storm DR. 1999. Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23:11-14.
28. Jung AB, Bennett JP Jr. 1996. Development of striatal dopaminergic function. III. Pre- and postnatal development of striatal and cortical mRNAs for the neurotrophin receptors trkBRK+ and trkC and their regulation by synaptic dopamine. Dev Brain Res 94:133-143.
29. Kalivas PW, Stewart J. 1991. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244.
30. Katoh-Semba R, Semba R, Takeuchi IK, Kato K. 1998. Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3. Neurosci Res 31:227-234.
31. Koob GF. 1988. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
32. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T. 1995. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:8856-8860.
33. Kwon YW, Gurney ME. 1994. Systemic injections of ciliary neurotrophic factor induce sprouting by adult motor neurons. Neuroreport 5:789-792.
34. Lorrain DS, Arnold GM, Vezina P. 2000. Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule. Behav Brain Res 107:9-19.
35. Maisonpierre PC, Belluscio L, Friedman B, Alderson RF, Weigand SJ, Furth ME, Lindsay RM, Yancopoulos GD. 1990. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 5:501-509.
36. Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE. 2000. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20:771-782.
37. Martin-Iverson MT, Altar CA. 1996. Spontaneous behaviors of rats are differentially affected by substantia nigra infusions of brain-derived neurotophic factor and neurotrophin-3. Eur J Neurosci 8:1696-1706.
38. Martin-Iverson MT, Todd KG, Altar CA. 1994. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J Neurosci 14:1262-1270.
39. Martinez-Serrano A, Bjorklund A. 1996. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J Neurosci 16:4604-4616.
40. Mendrek A, Blaha CD, Phillips AG. 1998. Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ration schedule. Psychopharmacology 135:416-422.
41. Messer CJ, Eisch AJ, Carlezon WA Jr, Whisler K, Shen L, Wolf DH, Westphal H, Collins F, Russell DS, Nestler EJ. 2000. Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26:247-257.
42. Mizuno K, Carnahan J, Nawa H. 1994. Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev Biol 165:243-256.
43. Nakao N, Kokaia Z, Odin P, Lindvall O. 1995. Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons. Exp Neurol 131:1-10.
44. Nakao N, Odin P, Lindvall O, Brundin P. 1996. Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurons in culture. Exp Neurol 138:144-157.
45. Nestler EJ. 1997. Molecular mechanisms of opiate and cocaine addiction. Curr Opin Neurobiol 7:713-719.
46. Numan S, Seroogy KB. 1997. Increased expression of trkB mRNA in rat caudate-putamen following 6-OHDA lesions of the nigrostriatal pathway. Eur J Neurosci 9:489-495.
47. Numan S, Seroogy KB. 1999. Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J Comp Neurol 403:295-308.
48. Paxinos G, Watson C. 1997. The rat brain in stereotaxic coordinates, 3rd ed. New York: Academic Press.
49. Pierce RC, Kalivas PW. 1997. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25:192-216.
50. Pierce RC, Pierce-Bancroft AF, Prasad BM. 1999. Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/mitogen-activated protein kinase signal transduction cascade. J Neurosci 19:8685-8695.
51. Ramirez JJ, Finklestein SP, Keller J, Abrams W, George MN, Parakh T. 1999. Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats. Neuroreport 10:1201-1204.
52. Reynolds AJ, Bartlett SE, Hendry IA. 2000. Molecular mechanisms regulating the retrograde axonal transport of neurotrophins. Brain Res Rev 33:169-178.
53. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
54. Robinson TE, Kolb B. 1997. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17:8491-8497.
55. Robinson TE, Kolb B. 1999. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 11:1598-1604.
56. Robinson TE, Gorny G, Mitton E, Kolb B. 2001. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 39:257-266.
57. Rosenblad C, Kirik D, Bjorklund A. 2000. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Exp Neurol 161:503-516.
58. Schnell L, Schneider R, Kolbeck R, Barde YA, Schwab ME. 1994. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 367:170-173.
59. Segal RA, Greenberg ME. 1996. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 19:463-489.
60. Seroogy KB, Lundgren KH, Tran TMD, Guthrie KM, Isackson PJ, Gall CM. 1994. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J Comp Neurol 342:321-334.
61. Sgambato V, Vanhoutte P, Pages C, Rogard M, Hipskind R, Besson MJ, Caboche J. 1998. In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J Neurosci 18:214-226.
62. Solbrig MV, Koob GF, Parsons LH, Kadota T, Horscroft N, Briese T, Lipkin WI. 2000. Neurotrophic factor expression after CNS viral injury produces enhanced sensitivity to psychostimulants: potential mechanism for addiction vulnerability. J Neurosci 20:RC104.
63. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C. 1992. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem 59:99-106.
64. Tafreshi AP, Zhou XF, Rush RA. 1998. Endogenous nerve growth factor and neurotrophin-3 act simultaneously to ensure the survival of postnatal sympathetic neurons in vivo. Neuroscience 83:373-380.
65. Timmusk T, Belluardo N, Metsis M, Persson H. 1993. Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues. Eur J Neurosci 5:605-613.
66. Valjent E, Corvol JC, Pages C, Besson MJ, Maldonado R, Caboche J. 2000. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J Neurosci 20:8701-8709.
67. Vanhoutte P, Barnier TV, Guibert B, Pages C, Besson MJ, Hipskind RA, Caboche J. 1999. Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol Cell Biol 19:136-146.
68. Ventimiglia R, Mather PE, Jones BE, Lindsay RM. 1995. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 7:213-222.
69. White FJ, Kalivas PW. 1998. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51:141-153.
70. White FJ, Xiu Y-H, Henry DJ, Zhang X-F. 1995. Neurophysiological alterations in the mesocorticolimbic dopamine system during repeated cocaine administration. In: Hammer R, editor. The neurobiology of cocaine addiction. Boca Raton, FL: CRC Press. p 99-120.
71. Wise RA, Bozarth MA. 1987. A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.
72. Yan Q, Radeke MJ, Matheson CR, Talvenheimo J, Welcher AA, Feinstein SC. 1997. Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J Comp Neurol 378:135-157.
73. Yurek DM, Fletcher-Turner A. 2001. Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion. Brain Res 891:228-235.
74. Zhou XF, Rush R. 1995. Sympathetic neurons in neonatal rats require endogenous neurotrophin-3 for survival. J Neurosci 15:6521-6530.
75. Zhou XF, Zettler C, Rush RA. 1994. An improved procedure for the immunohistochemical localization of nerve growth factor-like immunoreactivity. J Neurosci Methods 54:95-102.
76. Zhou XF, Cameron D, Rush RA. 1998. Endogenous neurotrophin-3 supports the survival of a subpopulation of sensory neurons in neonatal rat. Neuroscience 86:1155-1164.